Rebecca E. Mcfall

Hematology | Oncology

4440 W 95th St
Oak Lawn, IL 60453

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 1 publications

Docetaxel, bevacizumab, and gemcitabine for very high risk sarcomas in adolescents and young adults: A single-center experience.

Docetaxel, bevacizumab, and gemcitabine for very high risk sarcomas in adolescents and young adults: A single-center experience.

Journal: Pediatric blood & cancer

Published: March 27, 2016

Showing 1-1 of 1

Last Updated: 09/26/2026